Search

The applications of mesotherapy in aesthetic medicine

Mesotherapy is a modern form of therapy that consists of injecting medicines, vitamins and minerals as close as possible to the area that needs treatment. It is an astonishingly effective technique in aesthetic medicine as it treats layers of the...

From clinician to creator: taking your brand to the next level through experience-based marketing

Woman with Plastic Surgery “addiction” on how it nearly destroyed her marriage (and her face) Huffington Post, 4 November 2015 Cosmetic Crisis Waiting to Happen BBC News, 23 April 2012 I was blinded by fillers: One woman’s horrifying story of...

Plastic surgery founding father Ivo Pitanguy on life, learning and legends – remembering a giant

World renowned Plastic Surgeon Ivo Pitanguy passed away on 6 August 2016 at the age of 93 just a day after carrying the Olympic torch for the Rio Games. Read on to learn about the life of this giant of...

Building sustainable global partnerships – the BFIRST perspective on future-proofing global plastic surgery

The British Foundation for International Surgery and Training (BFIRST) marks their 10-year anniversary this year as an organisation. As the international outreach arm of the British Association of Plastic, Reconstructive & Aesthetic Surgeons (BAPRAS), BFIRST focuses on supporting surgeons in...

Informed consent and failure to disclose – legal perspectives for aesthetic surgeons

As litigation and legal claims in aesthetic surgery and medicine continue to rise, informed consent is not only a legal imperative but also essential in protecting yourself and your business. Lee Seng Khoo and Francesco Mazzarone, from the world-renowned Ivo...

A short overview of the evolution of botulinum toxin type A formulations

Botulinum toxin type A (BoNT-A) is a potent neurotoxin produced by the bacterium Clostridium botulinum [1]. BoNT-A has been used for various therapeutic and aesthetic purposes, including the treatment of muscle disorders, chronic pain and facial wrinkles [2-4]. Over the...